Association of a single nucleotide polymorphism in the lipoxygenase ALOX15 5′-flanking region (-5229G/A) with bone mineral density

Journal of Bone and Mineral Metabolism

Volumn 23, Issue 3, 2005, Pages 226-230

  Urano, Tomohiko ^a   Shiraki, Masataka ^b   Fujita, Masayo ^a,c   Hosoi, Takayuki ^d   Orimo, Hajime ^e   Ouchi, Yasuyoshi ^a   Inoue, Satoshi ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b RESEARCH INSTITUTE AND PRACTICE FOR INVOLUTIONAL DISEASES   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d Tokyo Metropolitan Institute of Gerontology   (Japan)

^e National Hospital Organization Kyoto Medical Center   (Japan)

Author keywords

Adipogenesis; ALOX15; Bone mineral density; Osteoporosis; Polymorphism; PPAR

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE;

ADULT; AGED; ALLELE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LUMBAR SPINE; NORMAL HUMAN; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ARACHIDONATE 15-LIPOXYGENASE; BONE DENSITY; FEMALE; HUMANS; JAPAN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 18044388164     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-004-0588-x     Document Type: Article

References (43)

1. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137-1141
2. Flicker L, Hopper JL, Rodgers L, Kaymakci B, Green RM, Wark JD (1995) Bone density determinants in elderly women: a twin study. J Bone Miner Res 10:1607-1613
3. Young D, Hopper JL, Nowson CA, Green RM, Sherwin AJ, Kaymakci B, Smid M, Guest CS, Larkins RG, Wark JD (1995) Determinants of bone mass in 10 to 26 year old females: a twin study. J Bone Miner Res 10:558-567
4. Krall EA, Dawson-Hughes B (1993) Heritable and life-style determinants of bone mineral density. J Bone Miner Res 8:1-9
5. Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G (1995) Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10:2017-2022
6. Nelson DA, Kleerekoper M (1997) The search for the osteoporosis gene. J Clin Endocrinol Metab 82:989-990
7. Liu YZ, Liu YJ, Recker RR, Deng HW (2002) Molecular studies of identification of genes for osteoporosis: the 2002 update. J Endocrinol 177:147-196
8. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA (1994) Prediction of bone density from vitamin D receptor alleles. Nature (Lond) 367:284-287
9. Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van Leeuwen JP, Pols HA, Ralston SH (1998) Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:1016-1021
10. Ogawa S, Urano T, Hosoi T, Miyao M, Hoshino S, Fujita M, Shiraki M, Orimo H, Ouchi Y, Inoue S (1999) Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts. Biochem Biophys Res Commun 260:122-126
11. Urano T, Shiraki M, Ezura Y, Fujita M, Sekine E, Hoshino S, Hosoi T, Orimo H, Emi M, Ouchi Y, Inoue S (2004) Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J Bone Miner Metab 22:341-345
12. Meunier P, Aaron J, Edouard C, Vignon G (1971) Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop 80:147-154
13. Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frisch B, Mallmann B, Eisenmenger W, Gilg T (1987) Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone (NY) 8:157-164
14. Wronski TJ, Walsh CC, Ignaszewski LA (1986) Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone (NY) 7:119-123
15. Miniare P, Meunier PJ, Edouard C, Bernard J, Courpron J, Bourret J (1974) Quantitative histological data on disuse osteoporosis. Calcif Tissue Res 17:57-73
16. Wang GW, Sweet D, Reger S, Thompson R (1977) Fat cell changes as a mechanism of avascular necrosis in the femoral head in cortisone-treated rabbits. J Bone Joint Surg 59A:729-735
17. Klein RF, Allard J, Avnur Z, Nikolcheva T, Rotstein D, Carlos AS, Shea M, Waters RV, Belknap JK, Peltz G, Orwoll ES (2004) Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303:229-232
18. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK (1999) Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature (Lond) 400:378-382
19. Kuhn H, Walther M, Kuban RJ, Wiesner R, Rathmann J, Kuhn H (2002) Prostaglandins Other Lipid Mediat 68-69:263-290
20. Nosjean O, Boutin JA (2002) Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? Cell Signal 14:573-583
21. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL (2002) Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143:2376-2384
22. Khan E, Abu-Amer Y (2003) Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts. J Lab Clin Med 142:29-34
23. Krieg P, Marks F, Furstenberger G (2001) A gene cluster encoding human epidermis-type lipoxygenases at chromosome 17pl3.1: cloning, physical mapping, and expression. Genomics 73:323-330
24. Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, Hozawa A, Matsubara M, Kitaoka H, Tsuji I, Araki T, Satoh H, Hisamichi S, Imai Y, Ogihara T (2001) Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 38:1321-1324
25. Kelavkar U, Wang S, Montero A, Murtagh J, Shah K, Badr K (1998) Human 15-lipoxygenase gene promoter: analysis and identification of DNA binding sites for IL-13-induced regulatory factors in monocytes. Mol Biol Rep 25:173-182
26. Kamitani H, Kameda H, Kelavkar UP, Eling T (2000) A GATA binding site is involved in the regulation of 15-lipoxygenase-1 expression in human colorectal carcinoma cell line, caco-2. FEBS Lett 467:341-734
27. Liu C, Xu D, Sjoberg J, Forsell P, Bjorkholm M, Claesson HE (2004) Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res 297:61-67
28. Kamitani H, Taniura S, Ikawa H, Watanabe T, Kelavkar UP, Eling TE (2001) Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. Carcinogenesis (Oxf) 22:187-191
29. Shankaranarayanan P, Chaitidis P, Kuhn H, Nigam S (2001) Acetylation by histone acetyltransferase CREB-binding protein/ p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J Biol Chem 276:42753-42760
30. Kirkland JL, Dobson DE (1997) Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat tissue function. J Am Geriatr Soc 45:959-967
31. Justesen J, Stenderup K, Ebbesen EN, Mosekilde, Steiniche T, Kassem M (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171
32. Chan GK, Duque G (2002) Age-related bone loss: old bone, new facts. Gerontology 48:62-71
33. Daiscro DD Jr, Vogel RL, Johnson TE, Witherup KM, Pitzenberger SM, Rutledge SJ, Prescott DJ, Rodan GA, Schmidt A (1998) High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res 13:96-106
34. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I (2002) Adipogenesis and aging: does aging make fat go MAD? Exp Gerontol 37:757-767
35. 3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). Exp Gerontol 39:333-338
36. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL (2002) Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143:2376-2384
37. Kiefer CR, Snyder LM (2000) Oxidation and erythrocyte senescence. Curr Opin Hematol 7:113-116
38. Spiteller G (2001) Lipid peroxidation in aging and age-dependent diseases. Exp Gerontol 36:1425-1457
39. Pratico D, Zhukareva V, Yao Y, Uryu K, Funk CD, Lawson JA, Trojanowski JQ, Lee VM (2004) 12/15-Lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am J Pathol 164:1655-1662
40. Karats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, Sigal E (2000) Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vase Biol 20:2100-2105
41. Shannon VR, Chanez P, Bousquet J, Holtzman MJ (1993) Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease. Am Rev Respir Dis 147:1024-1028
42. Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM (2000) 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst 92:1136-1142
43. Montero A, Badr KF (2000) 15-Lipoxygenase in glomerular inflammation. Exp Nephrol 8:14-19